Annual Short Term Debt
$1.55 M
+$1.17 M+304.43%
31 December 2023
Summary:
Esperion Therapeutics annual short term debt is currently $1.55 million, with the most recent change of +$1.17 million (+304.43%) on 31 December 2023. During the last 3 years, it has fallen by -$1.03 million (-39.97%). ESPR annual short term debt is now -89.81% below its all-time high of $15.24 million, reached on 31 December 2012.ESPR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$2.74 M
+$62.00 K+2.31%
30 September 2024
Summary:
Esperion Therapeutics quarterly short term debt is currently $2.74 million, with the most recent change of +$62.00 thousand (+2.31%) on 30 September 2024. Over the past year, it has increased by +$1.82 million (+198.58%). ESPR quarterly short term debt is now -82.02% below its all-time high of $15.24 million, reached on 31 December 2012.ESPR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +304.4% | +198.6% |
| 3 y3 years | -40.0% | +14.1% |
| 5 y5 years | +100.0% | +926.6% |
ESPR Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -40.0% | +304.4% | at high | +798.7% |
| 5 y | 5 years | -40.0% | at high | +926.6% | |
| alltime | all time | -89.8% | -82.0% |
Esperion Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.74 M(+2.3%) |
| June 2024 | - | $2.68 M(+5.5%) |
| Mar 2024 | - | $2.54 M(+63.5%) |
| Dec 2023 | $1.55 M(+304.4%) | $1.55 M(+69.2%) |
| Sept 2023 | - | $918.00 K(+33.6%) |
| June 2023 | - | $687.00 K(+125.2%) |
| Mar 2023 | - | $305.00 K(-20.6%) |
| Dec 2022 | $384.00 K(-72.4%) | $384.00 K(-44.6%) |
| Sept 2022 | - | $693.00 K(-27.6%) |
| June 2022 | - | $957.00 K(-21.4%) |
| Mar 2022 | - | $1.22 M(-12.6%) |
| Dec 2021 | $1.39 M(-46.2%) | $1.39 M(-42.0%) |
| Sept 2021 | - | $2.40 M(+2.4%) |
| June 2021 | - | $2.35 M(+0.3%) |
| Mar 2021 | - | $2.34 M(-9.5%) |
| Dec 2020 | $2.59 M(+469.8%) | $2.59 M(-1.7%) |
| Sept 2020 | - | $2.63 M(+17.9%) |
| June 2020 | - | $2.23 M(+16.7%) |
| Mar 2020 | - | $1.91 M(+321.4%) |
| Dec 2019 | $454.00 K | $454.00 K(+70.0%) |
| Sept 2019 | - | $267.00 K(+34.2%) |
| June 2019 | - | $199.00 K(+8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $184.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2018 | - | $152.00 K(-74.8%) |
| Mar 2018 | - | $603.00 K(-42.3%) |
| Dec 2017 | $1.04 M(-38.9%) | $1.04 M(-29.3%) |
| Sept 2017 | - | $1.48 M(-16.2%) |
| June 2017 | - | $1.76 M(+1.6%) |
| Mar 2017 | - | $1.74 M(+1.6%) |
| Dec 2016 | $1.71 M(+6.5%) | $1.71 M(+1.6%) |
| Sept 2016 | - | $1.68 M(+1.6%) |
| June 2016 | - | $1.66 M(+1.7%) |
| Mar 2016 | - | $1.63 M(+1.6%) |
| Dec 2015 | $1.60 M(+151.4%) | $1.60 M(+1.6%) |
| Sept 2015 | - | $1.58 M(+10.6%) |
| June 2015 | - | $1.43 M(+38.5%) |
| Mar 2015 | - | $1.03 M(+61.4%) |
| Dec 2014 | $638.00 K(-95.8%) | $638.00 K(+152.2%) |
| Sept 2014 | - | $253.00 K(-98.3%) |
| Dec 2012 | $15.24 M(+1336.5%) | $15.24 M |
| Dec 2002 | $1.06 M(+22.9%) | - |
| Dec 2001 | $863.00 K(+23.8%) | - |
| Dec 2000 | $697.00 K(+40.8%) | - |
| Dec 1999 | $495.00 K | - |
FAQ
- What is Esperion Therapeutics annual short term debt?
- What is the all time high annual short term debt for Esperion Therapeutics?
- What is Esperion Therapeutics annual short term debt year-on-year change?
- What is Esperion Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly short term debt year-on-year change?
What is Esperion Therapeutics annual short term debt?
The current annual short term debt of ESPR is $1.55 M
What is the all time high annual short term debt for Esperion Therapeutics?
Esperion Therapeutics all-time high annual short term debt is $15.24 M
What is Esperion Therapeutics annual short term debt year-on-year change?
Over the past year, ESPR annual short term debt has changed by +$1.17 M (+304.43%)
What is Esperion Therapeutics quarterly short term debt?
The current quarterly short term debt of ESPR is $2.74 M
What is the all time high quarterly short term debt for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly short term debt is $15.24 M
What is Esperion Therapeutics quarterly short term debt year-on-year change?
Over the past year, ESPR quarterly short term debt has changed by +$1.82 M (+198.58%)